natureindex.com

Sitemap

Sign up

Nature Index

  • Home
  • News
    • News home
    • Listings
    • News
    • Comment
    • Nature Index 360°
    • Q&A
    • Dataviz
    • News archive
  • Current Index
    • Institution tables
    • Institutions A-Z
    • Research highlights
    • Country/territory tables
    • Articles
    • Collaborations
    • City maps
    • Data feed
    • Custom tables
    • Custom graphs
  • Annual tables
    • 2020 tables
    • 2019 tables
    • 2018 tables
    • 2017 tables
    • 2016 tables
  • Supplements
    • Nature Index supplements
    • Nature Index 2020 Artificial Intelligence
    • Nature Index 2020 Germany
    • Nature Index 2020 Science Cities
    • Nature Index 2020 South Korea
    • Nature Index 2020 Cancer
    • Nature Index 2019 Materials Science
    • Nature Index 2019 Collaboration and Big Science
    • Nature Index 2019 Young Universities
    • Nature Index 2019 Biomedical Sciences
    • Nature Index 2019 Japan
    • Nature Index 2018 China
    • Nature Index 2018 Science Cities
    • Nature Index 2018 Rising Stars
    • Nature Index 2018 Earth and Environmental Sciences
    • Nature Index 2018 Japan
    • Nature Index 2017 Science Inc.
    • Nature Index 2017 United States
    • Nature Index 2017 Science Cities
    • Nature Index 2017 Saudi Arabia
    • Nature Index 2017 Innovation
    • Nature Index 2017 China
    • Nature Index 2017 Japan
    • Nature Index 2016 Collaborations
    • Nature Index 2016 Australia and New Zealand
    • Nature Index 2016 Rising Stars
    • Nature Index 2016 Saudi Arabia
    • Nature Index 2016 Japan
    • Custom reports
  • Client services
    • Client services
    • 2020 Brochure
  • About
    • FAQ
    • Glossary of terms
    • Knowledge base
    • Nature Index journals
    • Journal selection
    • Using the Index
    • Newsletter signup
  1. Home
  2. Articles
  3. BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers

BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers

Journal: Science Translational Medicine

Published: 2020-02-19

DOI: 10.1126/scitranslmed.aax2625

Affiliations: 17

Authors: 34

Go to article
Institutions Authors Share
Department of Translational Research, Curie Institute, France
0.35
Developmental Biology, Cancer, Genetics and Epigenetics, Institut Curie, France
0.10
Laboratory of Tumor and Development Biology (LBTD), ULg, Belgium
0.09
Cancer GenomiCs.nl (CGC.nl), Netherlands
0.06
Department of Pathology, Institut Curie, France
0.06
Curie Institute, France
0.06
Biopôle, ENVA, France
0.04
Animal Physiopathology and Biotherapy of the Muscle and Nervous System (PANTHER), France
0.03
Bioinformatics and Computational Systems Biology of Cancer, France
0.03
Genetics and Biology of Cancers, France
0.03
Signalisation, Neurobiologie et Cancer, France
0.03
Queen's Cancer Research Institute (QCRI), Queen's University, Canada
0.03
NIH NCI Laboratory of Molecular Pharmacology (LMP), United States of America (USA)
0.03
Department of Medical Oncology, Curie Institute, France
0.02
Physiologie Animale et Systèmes d'Elevage (PHASE), INRAE, France
0.01
Department of Surgery, Curie Institute, France
0.01
Immunity and Cancer Unit, France
0.01

Return

Latest supplement

Nature Index 2020 Artificial Intelligence

Nature Index 2020 Artificial Intelligence

Artificial intelligence is one of the most rapidly advancing and controversial topics in scientific research. As investments and revenues soar year-on-year and nations vie for leadership in the field, AI research output continues its steep, upward trajectory. But there are significant ethical and technical challenges to overcome.

Access free

Nature Index 2020 Germany

Nature Index 2020 Germany

Germany's position as a research giant is defined by its strong and steady science funding and long-term investment in basic research. But although national science organizations are thriving under funding certainty, there are concerns that some universities will be left behind.

Access free

Sponsored content

  • Discover the latest research from Ireland

Contact us
Follow us on Twitter
Follow us on Facebook

Research highlights of partners

Efficient algae behind mass extinction

University of Science and Technology of China (USTC)

27 May 2019

Reviving biomedical polymer production

Vidyasirimedhi Institute of Science and Technology (VISTEC)

31 Jul 2019

Mapping the water-splitting power of catalysts

Kanazawa University (KU)

29 May 2020

Research highlights

Sign up for the free weekly Nature Index newsletter
Sign up

Useful links

  • FAQ

  • User tips

  • The Nature Index journals

Advertisement

Enhanced profiles

  • FAQ
  • Client Services
  • Institution outputs
  • Country outputs
  • News
  • Supplements
  • Privacy policy
  • California Privacy Statement
  • Use of cookies
  • Manage cookies/Do Not Sell My Info
  • Legal notice
  • Terms
  • Nature.com
  • Nature News
  • Nature Careers
  • Nature Asia-Pacific

Springer Nature

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER